In the past week, GH stock has gone up by 12.98%, with a monthly gain of 4.29% and a quarterly plunge of -30.85%. The volatility ratio for the week is 5.31%, and the volatility levels for the last 30 days are 3.90% for Guardant Health Inc The simple moving average for the last 20 days is 8.51% for GH stock, with a simple moving average of -3.90% for the last 200 days.
Is It Worth Investing in Guardant Health Inc (NASDAQ: GH) Right Now?
The stock has a 36-month beta value of 1.10. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for GH is 117.72M, and at present, short sellers hold a 11.62% of that float. On October 31, 2024, the average trading volume of GH was 2.21M shares.
GH) stock’s latest price update
Guardant Health Inc (NASDAQ: GH)’s stock price has increased by 5.87 compared to its previous closing price of 21.79. However, the company has seen a 12.98% increase in its stock price over the last five trading sessions. fool.com reported 2024-10-30 that There’s nothing like free publicity to help goose the sales of a relatively new product.
Analysts’ Opinion of GH
Many brokerage firms have already submitted their reports for GH stocks, with Guggenheim repeating the rating for GH by listing it as a “Buy.” The predicted price for GH in the upcoming period, according to Guggenheim is $36 based on the research report published on June 28, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see GH reach a price target of $32. The rating they have provided for GH stocks is “Buy” according to the report published on June 03rd, 2024.
Craig Hallum gave a rating of “Buy” to GH, setting the target price at $28 in the report published on April 24th of the current year.
GH Trading at -1.59% from the 50-Day Moving Average
After a stumble in the market that brought GH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.72% of loss for the given period.
Volatility was left at 3.90%, however, over the last 30 days, the volatility rate increased by 5.31%, as shares surge +3.18% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.65% lower at present.
During the last 5 trading sessions, GH rose by +12.98%, which changed the moving average for the period of 200-days by -4.67% in comparison to the 20-day moving average, which settled at $21.26. In addition, Guardant Health Inc saw -14.71% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GH starting from Joyce Meghan V., who sale 100 shares at the price of $27.87 back on Jun 04 ’24. After this action, Joyce Meghan V. now owns 4,621 shares of Guardant Health Inc, valued at $2,787 using the latest closing price.
Kalia Kumud, the Chief Information Officer of Guardant Health Inc, purchase 2,187 shares at $17.82 during a trade that took place back on Mar 18 ’24, which means that Kalia Kumud is holding 12,722 shares at $38,963 based on the most recent closing price.
Stock Fundamentals for GH
Current profitability levels for the company are sitting at:
- -0.79 for the present operating margin
- 0.82 for the gross margin
The net margin for Guardant Health Inc stands at -0.76. The total capital return value is set at -0.36. Equity return is now at value -337.16, with -28.46 for asset returns.
Based on Guardant Health Inc (GH), the company’s capital structure generated 1.0 points at debt to capital in total, while cash flow to debt ratio is standing at -0.24. The debt to equity ratio resting at -724.69. The interest coverage ratio of the stock is 198.43.
Currently, EBITDA for the company is -519.63 million with net debt to EBITDA at -0.61. When we switch over and look at the enterprise to sales, we see a ratio of 4.88. The receivables turnover for the company is 6.4for trailing twelve months and the total asset turnover is 0.4. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.40.
Conclusion
To sum up, Guardant Health Inc (GH) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
